Home
About this Panel
Biography of Presenters
Comment on this Program
Video Preferences
A Profoundly Important Endeavor
10:43
President Lawrence H. Summers
Enormous Implications
3:16
Provost Steven E. Hyman, M.D.
A Great Need
7:26
David T. Scadden, M.D.
A Singular Goal
12:03
Professor Douglas A. Melton
Audience Question and Answer
21:39
Audience & Panel
Audience & Panel
Question:
Is Harvard working in conjunction with other universities here or abroad on stem cell research?
Question:
What are the implications for a private stem cell institute collaborating with an institute that's receiving public monies?
Question:
My question goes to the heart of the ethical issues: Aren't you creating a unique human organism, capable of directing its own development, and then destroying it?
Question:
Wouldn't it be wise to pause on the controversial matter of embryo cloning, proceed much more vigorously with embryo stem cell research, and then return to the question of cloning after we've addressed some of the problems currently associated with it?
Question:
I don't understand why the commitment to embryonic cell lines doesn't raise eventual transplantation problems. Why aren't we looking more closely at materials that can be derived from each infant at birth?
Question:
It's my understanding that stem cell research is one aspect or subset of regenerative medicine. What is Harvard's focus in this area? Is your thinking that the ultimate solution will come from stem cell research and its potential?
Question:
Given this stem cell research, what are the implications on matters like social security and other entitlement programs for a school like Harvard?
Question:
At this early stage, what is the vision of the Harvard Stem Cell Institute for collaborating with other groups in England and elsewhere in Europe, incorporating their innovative work and avoiding duplication, as we pioneer in this very new area?
Question:
How are you going to confront the religious right and others who don't believe in doing this kind of research? Do we have the strength to face this opposition?
Question:
What stem cell work is being done on spinal chord injury, Parkinson's, and Alzheimer's? What do you foresee as the future of stem cell research in combating these diseases?
Question:
I wonder if you have plans to use somatic cell nuclear transfer (SCNT) to derive stem cells or not?
Question:
Would you comment on the potential applications and impediments of this approach and stem cell technology in the treatment of multiple sclerosis?
Question:
It's my understanding that there isn't a yet cure for amyotrophic sclerosis, or Lou Gehrig's disease, largely because so few people have it and therefore not enough money has been given for research and treatment. Can this disease be helped by stem cell work?
© Copyright 2006 President and Fellows of Harvard College. All rights reserved.